Department of Environmental Science, Baylor University, Waco, Texas, USA.
Prog Mol Biol Transl Sci. 2012;112:231-58. doi: 10.1016/B978-0-12-415813-9.00008-8.
Pharmaceuticals in the environment are often present at trace levels (e.g., ng/L) in surface waters and effluents of developed countries, yet represent contaminants of emerging concern. Attributes of many of these substances, such as potency, chirality, and ionization, present challenges to historical environmental risk assessment and management paradigms. In this chapter, we critically examine several important aspects of pharmaceuticals, specifically highlighting some of the lessons we have learned from studying these substances in the environment over the past 15 years. We submit that incorporating such "lessons learned" during environmental risk assessments promises to reduce uncertainties and support more sustainable management efforts.
环境中的药品通常以痕量(例如,ng/L)形式存在于发达国家的地表水和废水中,但却是新兴关注的污染物。这些物质的许多属性,如效力、手性和离子化,对历史环境风险评估和管理范式构成了挑战。在本章中,我们批判性地研究了药品的几个重要方面,特别是强调了我们在过去 15 年研究这些物质在环境中的应用中所学到的一些经验教训。我们认为,在环境风险评估中纳入这些“经验教训”有望减少不确定性并支持更可持续的管理工作。